Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02169180 |
|---|---|
| Brief Title: | Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Relapsed or Refractory Mantle Cell Lymphoma |
| First Submitted : | June 19, 2014 |
| First Submitted that Met QC Criteria : | June 20, 2014 |
| First Posted : | June 23, 2014 (Estimate) |
| Last Update Submitted that Met QC Criteria : | January 23, 2017 |
| Last Update Posted : | January 24, 2017 (Estimate) |